Alzheimer's Drug Discovery Foundation

Neuroimaging and CSF Biomarker RFP (Therapeutics Funding Programs - Biomarkers)

Who can apply: ADDF provides funding to academic centers and biotechnology companies from around the world advancing biomarker development for Alzheimer's disease and related dementias. Detailed eligibility is on the program page.

Deadline: LOI date has passed; invited full proposal deadline listed as December 7, 2026.

SpeechDx

Who can apply: Researchers, companies, and other entities interested in developing speech-based biomarker tools may apply to join the SpeechDx initiative. Applications are assessed for mission alignment and ethical compliance. New participants and sites are not currently being recruited, but organizations may contact the initiative for information.

Deadline: No application deadline stated; new subjects and participating sites are not currently being recruited.

Therapeutics Funding Programs (ADDF)

Who can apply: Open to academic centers and biotechs advancing therapeutic and biomarker development for Alzheimer's and related dementias. Specific eligibility varies by RFP.

Deadline: Letter of Intent: September 14, 2026; Invited Full Proposal: TBD

Prevention RFP (Therapeutics Prevention Pipeline)

Who can apply: Projects testing prevention approaches or whether drug use/choice affects dementia risk. See RFP for details.